From oral solid dosage forms to high-end complex injectables, from chemical drugs to TCM natural medicines — Taikomed has built 6 core R&D platforms around formulation technology barriers, covering the complete technology chain of SR/CR, nano-delivery, lipid emulsion/multi-chamber bags, TCM R&D, synthesis, and pharmaceutical analysis.
Each technology platform has a dedicated detail page covering technology routes, service matrix, R&D workflow, and quality control systems. Click the cards below to visit each platform's dedicated landing page.
Covering four major SR/CR technology routes: matrix, membrane-controlled, osmotic pump, and pulsatile release systems. End-to-end consistency evaluation CRO services from RLD reverse engineering, preformulation studies, formulation & process development, to BE testing and CTD dossier submission.
Explore SR/CR CRO Services →Covering mainstream nano-delivery systems including liposomes, nanoparticles, lipid emulsion/drug-loaded emulsion, microemulsion, and nanoemulsion. Full-process CRO services supporting generic drug development, Class 2.2 modified new drugs, and high-end complex injectables — from formulation design to sterilization process validation.
Explore Nano-Delivery CRO Services →One of the few CROs in China with a full-spectrum technology platform. Established a 20+ product project matrix covering parenteral nutrition lipid emulsions, drug-loaded lipid emulsion injections, multi-chamber bag injections, and Class 2.2 modified new drug lipid emulsions — end-to-end R&D and regulatory submission.
Explore Lipid Emulsion / TPN CRO Services →Full-chain TCM R&D services from botanical origin identification to CTD dossier submission. Covering five major domains: classical famous formula development, TCM compound preparations, formula granule process research, hospital preparation conversion, and TCM secondary development — a one-stop solution guided by CDE TCM review requirements.
Explore TCM R&D CRO Services →Full-chain chemical synthesis CRO platform covering synthetic biology & enzyme catalysis, compound structural modification & resolution, chiral compound process studies, and genotoxic impurity & impurity process studies. With 60+ industrialized mature processes, from milligram-scale route exploration to kilogram-scale scale-up validation — providing process R&D and regulatory support compliant with ICH M7 requirements.
Explore Synthesis Platform →Equipped with LC-MS/MS, GC-MS/MS, ICP-MS, and other high-end analytical platforms, covering API quality research, solid dosage form (SR/CR) quality research, genotoxic impurity method development & validation, and elemental impurity method development & validation. Fully compliant with ICH Q2/Q3/M7/Q3D guidelines, covering all high-frequency CDE deficiency areas.
Explore Pharma Analysis Platform →Core technology is Taikomed's R&D foundation, but we go beyond technology. From pharmaceutical sciences to BE studies, from regulatory submission to commercial manufacturing — full-process CRO services that reduce your multi-vendor coordination costs.
Explore Our Full-Process CRO Services →